• 亚洲性色成人A片在线观看金沙_国产综合久久久久_免费人成视频在线_国产卡一卡二卡三无线乱码新区

    美国招商投资网
    美国国旗
    强生创新全球生态系统联系人名录67—2
    来源:网群国际    浏览:

    Innovation Accelerating a World Without Disease The World Without Disease Accelerator (WWDA) is a unique enterprise R&D group aligned with global commercial expertise andfocused on the discovery, development and delivery of disruptive products/technologies, business models and partnerships to advance the elimination of disease. The WWDA brings together distinct enabling capabilities in areas including the microbiome, immunosciences,predictive analytics and behavioral sciences to seed transformative growth opportunities and catalyze a paradigm shift in prevention,interception and cure strategies and solutions.

     

    Building on the 130-year legacy of Johnson & Johnson blending heart, science and ingenuity to tackle some of today’s most pressing public health challenges, we believe that all people - no matter where they live - deserve access to lifesaving innovation at the same time.

    Public HealthJOHNSON & Charting a bold, new, self-sustainable approach,Johnson & Johnson Global Public Health is pushing boundaries as the frst fully-dedicated organization within a healthcare company working to ensure that innovative treatments and technologies are available,affordable and accessible for the world’s most underserved populations.

     

    Combining R&D, novel access programs and business model innovation, in-country operations, and the power of multi-sectoral partnerships we are committed to unlocking the power of science to move beyond incremental improvement to achieve transformational outcomes and solve for HIV, tuberculosis and other high burden diseases which disproportionately impact people in low income countri***

    To achieve that we seek to partner within and outside Johnson & Johnson Family of Companies to deliver on the promise of improved health for all, everywhere.

     

    TB Expanding access and uptake of existing regimens for multidrugresistant TB (MDR-TB), developing simplifed treatment regimens and novel molecular approaches; companion diagnostics.

    Novel and simplifed treatment tools, including new formulations,point-of-care diagnostics and others; innovative prevention tools andstrategies, including vaccines, microbicides and other education/ empowerment programs.

     

    OTHERS Nontuberculous mycobacterial lung disease (NTM); Dengue prevention and treatment; Malaria prevention and treatment; Chagas disease; Obstetric fstula repair; preterm birth prevention; maternal/newborn survival; general surgery and trauma; pandemic preparedness and emerging threats (e.g., Ebola, Zika, etc.).

     

    Connect With Us

    External Innovation Contacts

     

    External Innovation

    William N. Hait, M.D., Ph.D.

    Global Head, Johnson & Johnson

    External Innovation

    E: jnjinnovation**[ta]**.jnj.com

     

    Strategic Investing

    Tom Heyman

    President, JJDC

    E: info-jjdc**[ta]**.jnj.com

     

    Company Incubation

    Melinda Richter

    Global Head, JLABS

    E: jlabs**[ta]**.jnj.com

     

    Innovation Center San Francisco,

    California, USA

    Rowan Chapman, Ph.D.

    Head, Johnson & Johnson Innovation,

    West North America and Australia

    E: jnjinnovation**[ta]**.jnj.com

     

    Innovation Center Shanghai, China

    Dan Wang, M.D., MBA, MPH

    Head, Johnson & Johnson Innovation,

    APAC (Asia Pacifc)

    E: jnjinnovation**[ta]**.jnj.com

     

    Innovation Center London, UK

    Sir Harpal Kumar, Dsc, MEng, MBA

    Head, Johnson & Johnson Innovation,

    EMEA (Europe, Middle East and Africa)

    E: jnjinnovation**[ta]**.jnj.com

     

    Innovation Center Boston, USA

    Michal Preminger, Ph.D., MBA

    Head, Johnson & Johnson Innovation,

    East North America

    E: jnjinnovation**[ta]**.jnj.com

     

    Lung Cancer Initiative

    Avrum Spira, M.D., M.S.C.

    Global Head, Lung Cancer Initiative

    E: aspira**[ta]**.jnj.com

     

    World Without Disease Accelerator

    Ben Wiegand

    Global Head, WWDA

    E: bwiegan**[ta]**.jnj.com

     

    Global Public Health

    Jaak Peeters

    Global Head, Global Public Health

    E: gph**[ta]**.jnj.com

     

    Health Technology

    Oliver Hsiang

    Global Head, Health Technology Partnerships

    & Corporate Development

    E: ohsiang**[ta]**.jnj.com

     

    Janssen R&D Leadership Contacts

     

    Cardiovascular & Metabolism

    James F. List, M.D., Ph.D.

    Global Therapeutic Head,

    Cardiovascular & Metabolism

    Janssen Research & Development

    Mathai Mammen, M.D., Ph.D.

    Global Head, Research & Development

    EARLY STAGE - J&J INNOVATION

    Mark Erion, Discovery

    E: merion**[ta]**.jnj.com

     

    Thomas Gustafson, West US & ANZ

    E: tgustaf5**[ta]**.jnj.com

     

    Jim Tobin, East US

    E: jtobin3**[ta]**.jnj.com

     

    Shamina Rangwala, Europe

    E: srangwal**[ta]**.jnj.com

     

    LATE STAGE - JBD

    Sarah Brennan

    E: sbrennan**[ta]**.jnj.com

     

    Scott Lundeen, Scientifc Licensing

    E: slundeen**[ta]**.jnj.com

     

    Oncology

    Peter Lebowitz, M.D., Ph.D.

    Global Therapeutic Head, Oncology

     

    EARLY STAGE - J&J INNOVATION

    Joseph Erhardt, Discovery

    E: jerhardt**[ta]**.jnj.com

     

    Sylvaine Cases, West US & ANZ

    E: scases**[ta]**.jnj.com

     

    Bob Radinsky, East US

    E: rradinsk**[ta]**.jnj.com

     

    Sonal Patel, Eur***

    E: spate203**[ta]**.jnj.com

     

    Stefan Hart, Asia Pacifc

    E: shart16**[ta]**.jnj.com

     

    LATE STAGE - JBD

    Deborah Watson

    E: dwatson4**[ta]**.jnj.com

     

    Mike Rycyzyn, Scientifc Licensing

    E: mrycyzyn**[ta]**.jnj.com

     

    Immunology

    David M. Lee, M.D., Ph.D.

    Global Therapeutic Head, Immunology

    EARLY STAGE - J&J INNOVATION

    Ian Anderson, Discovery

    E: ianders7**[ta]**.jnj.com

     

    Jackie Benson, West US & ANZ

    E: jbenson4**[ta]**.jnj.com

     

    Michael Elliott, East US

    E: melliot2**[ta]**.jnj.com

     

    LATE STAGE - JBD

    Johan Verbeeck

    E: jverbee2**[ta]**.jnj.com

     

    Simon Blake, Scientifc Licensing

    E: sblake5**[ta]**.jnj.com

     

    Discovery and Platforms

    Richard Tillyer, Ph.D.

    Global Head, Discovery, Product Development

    & Supply (DPDS)

    Beth Hill

    E: bhill4**[ta]**.jnj.com

     

    Trevor Howe, Europe

    E: thowe4**[ta]**.jnj.com

     

    Julian Bertschinger

    E: jbertsc**[ta]**.jnj.com

     

    Neuroscience

    Husseini K. Manji, M.D., F.R.C.P.C.

    Global Therapeutic Head, Neuroscience

    EARLY STAGE - J&J INNOVATION

    David Bredt, Discovery

    E: dbredt**[ta]**.jnj.com

     

    Guy Seabrook, West US & AZ

    E: gseabroo**[ta]**.jnj.com

     

    Eric Schaeffer, East US

    E: eschaef7**[ta]**.jnj.com

     

    Declan Jones, Europe

    E: djone119**[ta]**.jnj.com

     

    John Issac, Europe

    E: jisaac5**[ta]**.jnj.com

     

    LATE STAGE - JBD

    Lucinda Warren

    E: cwarren4**[ta]**.jnj.com

     

    Gregor Macdonald, Scientifc Licensing

    E: gmacdon1**[ta]**.jnj.com

     

    Infectious Diseases & Vaccines

    James Merson, Ph.D.

    Global Therapeutic Head, Infectious Diseases

    Johan Van Hoof, M.D.

    Global Therapeutic Head, Vaccines

    EARLY STAGE - J&J INNOVATION

    Debbie Law, Discovery

    E: dlaw2**[ta]**.jnj.com

     

    Kenneth Simmen, Global (Europe focused)

    E: ksimmen1**[ta]**.jnj.com

     

    Nicola La Monica, US & ANZ

    E: nlamonic**[ta]**.jnj.com

     

    LATE STAGE - JBD

    Marianne De Backer

    E: mdbacker**[ta]**.jnj.com

     

    Philippe Alen, Scientifc Licensing

    E: palen**[ta]**.jnj.com

     

    Pulmonary Hypertension

    Martin Fitchet, M.D.

    Global Therapeutic Head, Pulmonary Hypertension

    LATE STAGE - JBD

    Nicolas Franco

    E: nfranco9**[ta]**.jnj.com

     

    Joerg Laeuffer, Scientifc Licensing

    E: jlaeuff1**[ta]**.jnj.com

     

    Data Science

    Troy Sarich, Janssen R&D Strategy

    E: tsarich**[ta]**.jnj.com

     

    Najat Khan, Janssen R&D Strategy

    E: nkhan31**[ta]**.jnj.com

     

    Joseph Lehar, Oncology

    E: jlehar**[ta]**.jnj.com

     

    Guna Rajagopal, Genomics

    E: grajagop**[ta]**.jnj.com

     

    Vaibhav Narayan, Neuroscience

    E: vnaray16**[ta]**.jnj.com

     

    Emma Huang, J&J Innovation

    E: bhuang26**[ta]**.jnj.com

     

    Janssen Business Development

    Patrick Verheyen

    Global Head, Janssen Business Development

     

    Global Public Health

    Wim Parys, M.D.

    Head R&D, Global Public Health

    Jens Bitsch-Norhave

    E: jbitschn**[ta]**.jnj.com

     

    Johan Verbeeck

    E: jverbee2**[ta]**.jnj.com

     

    Consumer R&D Leadership and Business Development Contacts

     

    Global Consumer R&D

    Josh Ghaim, Ph.D.

    Chief Technology Offcer,

    Johnson & Johnson Family of Consumer Companies

    Fabiana Gargaro

    VP, Global Femcare R&D Deployment (LATAM)

    Consumer R&D Franchise Leaders

     

    Consumer R&D Regional Leaders

    Anna Prilutsky

    VP, Global Baby R&D

    Jonathan Miller

    VP, Global Oral Care/Wound Care R&D

    Jennifer Zhu

    VP, Global Beauty R&D

    Stephen Raven

    VP, Global Self-Care and

    R&D Deployment (EMEA)

    Adam Ricciardone

    VP, R&D Deployment (Asia Pacifc)

    Mona Nair

    VP, Global eCommerce New Initiatives & R&D

    Deployment (North America)

     

    Consumer External Innovation

    John Bell

    VP, External Innovation & Business Models

    EARLY STAGE - J&J INNOVATION

    Stephanie Robertson

    Senior Director, Consumer Scientifc

    Innovation (West US)

    E: srober18**[ta]**.jnj.com

     

    Stefanie Dhanda

    Senior Director, Scientifc Innovation,

    Consumer (East US)

    E: sdhanda**[ta]**.jnj.com

     

    Elena Fernandez-Kleinlein

    Senior Director, Scientifc Innovation,

    Consumer (Europe)

    E: efernkle**[ta]**.jnj.com

     

    Tyrone Mao

    Senior Director, Scientifc Innovation,

    Consumer (Asia Pacifc)

    E: tmao2**[ta]**.jnj.com

     

    Consumer Business Development

    Peter Kerrane

    Worldwide VP, Strategy & Business Development

    E: pkerrane**[ta]**.jnj.com

     

    Brian Shuster

    VP, Consumer Business Development

    E: bshuster**[ta]**.jnj.com

     

    Medical Devices R&D Leadership and Business Development Contacts

     

    Medical Devices R&D

    Peter Shen, Ph.D.

    Global Head of Research & Development,

    Johnson & Johnson Medical Devices Companies

    Medical Devices Business Development

    Susan Morano

    Global Head of Business Development,

    Johnson & Johnson Medical Devices Companies

    Medical Devices R&D Heads

    Euan Thomson

    Global Head, Digital Technologies

    and Advanced Innovation

    Beth McCombs

    Vice President, R&D, Ethicon

    Rob Laird

    Vice President, R&D, DePuy Synthes

    Avi Shalgi

    Vice President, R&D, Cardiovascular

    & Specialty Solutionst

     

    Jennifer Kozac

    VP, Business Development, New Growth Platforms

    E: jkozak**[ta]**.jnj.com

     

    Noam Krantz

    WW VP, Business Development, Ethicon

    E: nkrantz**[ta]**.jnj.com

     

    Christine Knoblauch

    VP, Business Development, DePuy Synthes

    E: cknobla2**[ta]**.jnj.com

     

    Biren Mehta

    VP, Business Development, Cardiovascular

    & Specialty Solutions

    E: bmehta5**[ta]**.jnj.com

     

    Vision R&D Leadership and Business Development Contacts

     

    Vision R&D

    Xiao-Yu Song, M.D., Ph.D.

    Global Head of Research & Development,

    Johnson & Johnson Vision

     

    Vision Business Development

    JD Moore

    Global Head of Business Development,

    Johnson & Johnson Vision

     

    Troy Wu

    Senior Director, Business Development, Surgical

    E: twu29**[ta]**.jnj.com

     

    Matthew Rieke

    Senior Director, Business Development, Surgical

    E: mrieke**[ta]**.jnj.com

     

    Tonja Danowski

    VP, Business Development, Vision Care

    E: tcurtis2**[ta]**.jnj.com

     

    Vision R&D Heads

    David Turner

    Head of R&D, Contact Lens Platform

    Griffth Altmann

    Head of R&D, Surgical Instrumentation

    Manohar Raheja

    Head of R&D, Ophthalmic Implant Platform

    Randall Pugh

    Head of Smart Device Technology

    Vision External Innovation

    EARLY STAGE - J&J INNOVATION

    Leonard Borrmann

    Head of External Innovation (West US)

    E: lborrman**[ta]**.jnj.com

     

    Hassan Chaouk

    Director of External Innovation (East US)

    E: hchaouk**[ta]**.jnj.com

     

    EMAIL US:

    jnjinnovation**[ta]**.jnj.com

     

    FOLLOW US ON TWITTER:

    **[ta]JNJInnovation

    VISIT OUR WEBSITE FOR MORE INFORMATION:

    HTTP://**jinnovation.com

    HTTP://**bs.jnjinnovation.com

    APPLY FOR A CHALLENGE:

    HTTP://**nnovation.com/challenges

    Johnson & Johnson Innovation, LLC ***

     

    项目合作:18361148798    或 点击这里给我发消息
    温馨提示:本站提供免费发布服务,但对信息的合法性、实时性、真实性和完整性,不承担任何责任。名录资源由会员为向全球展示品牌形象上传,个人信息均经处理后发布,如有遗漏戓涉嫌侵权他人及不愿展示形象的,请将“该页网址和需修改及删除的内容”发至本站邮箱戓留言给我们处理。凡注册会员并发布信息或名录资源的,均可定期获得全球项目参考及合作机会。本站名录资源概不对任何第三方开放,更不提供如交换、出售及查询等服务!
    项目合作及建议请留言:请理性留言,并遵守相关规定
    姓名: 手机: QQ号: 微信: 邮箱:
    验证码 点此换一张
    关于我们 招商培训 代理招商 代理投资 代理融资 代理政策 战略伙伴 服务外包
    广告报价 汇款方式 合作方式 免费发布 网群建设 诚聘英才 网站导航 设为首页